The new program requests that physicians provide up-front justification for certain medical equipment, which has a big impact on orthopedic and cardiac devices, according to the report. The news became public on Friday, and stock prices fell 1 percent for Smith & Nephew and about 4 percent for both Zimmer and Stryker.
Over last weekend, Medtronic shares dropped 6 percent, according to the report. Today’s prices are significantly lower than the closing prices last Friday. Stryker fell from $47.85 closing on Friday to $46.90 opening today; Zimmer is down from $49.26 to 27.57; Smith & Nephew is down from $46.07 to $45.18.
Related Articles on Orthopedic Devices:
Sanuwave’s Technology Stimulates Adult Stem Cell Proliferation Within the Body
Baxter International Acquires Synovis for $325M
Stryker to Close Two Gaymar Industries Locations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.